Drugs / Phenformin

Trials 2

20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT03026517 Jan 2017 → Jan 2025 melanoma Memorial Sloan Kettering Cancer Center Completed No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT05003492 Sep → Oct 2021 COVID-19 Amr kamel khalil Ahmed Unknown No outcome recorded

Evidence & citations 13 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Phenformin “Patients will be administered study medication (Inhaled 100-150 mg phenformin per day; or, if broken into 3 doses/day, 30-50 mg/dose.” NCT05003492 ↗
1

NCT03026517 ↗

Known as Debei ChEMBL registry synonym — accepted as the source's own label CHEMBL170988 ↗
Known as Dibotin s.r. ChEMBL registry synonym — accepted as the source's own label CHEMBL170988 ↗
Known as Fenformina ChEMBL registry synonym — accepted as the source's own label CHEMBL170988 ↗
Known as NSC-23100 ChEMBL registry synonym — accepted as the source's own label CHEMBL170988 ↗
Known as PHENFORMIN ACETIC ACID SALT ChEMBL registry synonym — accepted as the source's own label CHEMBL170988 ↗
Known as Phenformin hcl ChEMBL registry synonym — accepted as the source's own label CHEMBL170988 ↗
Known as PHENFORMIN HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL170988 ↗
Known as Phenformine ChEMBL registry synonym — accepted as the source's own label CHEMBL170988 ↗
Action Inhibit “Phenformin is expected to potentially attach to ACE2 receptors and lead to its downregulation, an inhibitory mechanism which may combat and block COVID-19 infection in lung...” NCT05003492 ↗
Modality Small molecule — CHEMBL170988 ↗
Route Inhaled “The phenformin will be utilized as aerosolized by inhalation for COVID-19 treatment” NCT05003492 ↗
Target ACE2 “Phenformin is expected to potentially attach to ACE2 receptors and lead to its downregulation” NCT05003492 ↗